Thoma Bravo Buys ConnectWise

Thoma Bravo buys ConnectWise.
   
Thoma Bravo’s software ability, general track record, and deep capital will allow ConnectWise to pursue a plan focused on organic growth and strategic acquisitions.  After the deal is complete, ConnectWise founder and CEO Arnie Bellini will move into an advisory role.  President and COO Jason Magee will take over as CEO.
    
Arnie Bellini said: ‘Five years ago, we began exploring all the financial options to speed up the ConnectWise mission and our partners’ success.  Thoma Bravo was the clear and obvious choice over an Initial Public Offering (IPO) and seven other private equity firms.  Thoma Bravo is the premier investor in Software-as-a-Service (SaaS) technology.  ConnectWise and Thoma Bravo have co-created a multi-year strategy that is aligned with our mission, vision, culture, and partners.  With this new relationship we plan to speed up our partners’ success worldwide.’
   
Jason Magee said: ‘Our success has been founded on deep interactions with our partners through our IT Nation events and peer groups.  We will continue to invest in our partner community and give the solutions they need to deliver technology as a service to the world.  I believe the Thoma Bravo partnership will speed up our ability to continually develop the platform our partners need to succeed through acquisitions and innovation.  We want to continue what we built this company on, which is striving to get our partners to be successful.  We’ll continue to do that internally as well as work with our customers to get them there.  2019 is going to be more of the same: cyber security, technology as a service, one click ecosystem, and customer success.’ 
  
Robert Sayle of Thoma Bravo said: ‘Thoma Bravo has long recognized ConnectWise’s position as a leader and pioneer in the Managed Service Provider (MSP) and broader IT services space.  For nearly 40 years, the company has been the market leader in providing the most comprehensive integrated software solutions to its community of partners.  Under the strong leadership of Arnie and the management team, ConnectWise has innovated and created top tier products and services, and we are thrilled to partner with Jason to enable further success and opportunity for ConnectWise partners.’
   
Partners can expect innovative cybersecurity solutions, advanced education, go to market tools, and a connected ecosystem to drive greater productivity and simplicity.  The partnership with Thoma Bravo will advance ConnectWise’s long-term vision and road map.  ConnectWise remains committed to driving partner success and growth.
   
Arnie Bellini added: ‘I feel good because I spent five years on a mission to find the right next chapter for ConnectWise.  You think about most acquisitions like this, you see a new CEO from the outside coming in.  This is from within.  The management team stays intact, the leadership stays intact, the mission and the vision stay intact.  Jason has more than 20 years of deep industry experience with MSPs and VARs.  Because Jason’s been in their shoes, he is committed to ConnectWise’s partners.  He will continue driving the passion, culture, and innovation that our partners and colleagues expect from us.’

Comments

Post a Comment

Popular posts from this blog

Pepsi Buys Rockstar

Pepsi buys Rockstar .     P epsiCo buys Rockstar Energy Beverages for $3.85 billion.     Founded in 2001, Rockstar is drinks designed for people leading an active lifestyle. Available in 20 flavors at convenience and grocery stores in 30 countries. Distributed by PepsiCo in North America since 2009. Supporting the Rockstar lifestyle across the globe through action sports, motorsports, and live music. Pepsi's energy portfolio also includes Kickstart , GameFuel, and Amp Energy.     The deal reflects the shift from reliance on sales of sugary, fizzy drinks toward options ranging from tea and coffee to still and sparkling water varieties, which appeal to health-conscious and younger consumers. Neither PepsiCo nor Coca-Cola owns a major brand in the energy drinks category, which is forecast to grow to more than $80 billion over the next five years and is now dominated by Red Bull.     2 00 countries and territories around the world enjoy ...
Read more

Compass Buys Marucci

Compass buys Marucci.     Compass Diversified Holdings buys Marucci Sports for $200 million.     Marucci Sports was founded in 2009 by Kurt Ainsworth, a retired pitcher for the San Francisco Giants and Baltimore Orioles, Joe Lawrence, a former second baseman for the Toronto Blue Jays, and Reed Dickens, a former White House Assistant Press Secretary under George W. Bush.     Marucci ’s first buy was Marucci Bat Company, launched out of a backyard shed in 2004. Ainsworth then led the buyout of an Amish-run Pennsylvania wood mill in 2008. This solidified Marucci's superior wood supply, and it still supplies all Marucci's wood today. In 2017 Marucci bought Victus , a baseball equipment maker known for its edgy designs and big attitude.     With vertically cohesive wood bat production, a global supplier group, and a client base of MVPs and World Series winners, Marucci and Victus are the top two bats among Big League players. T...
Read more

Gilead Buys Forty Seven

Gilead buys Forty Seven.     Gilead Sciences buys Forty Seven for $4.9 billion.     Forty Seven is a clinical-stage immuno-oncology firm developing therapies targeting cancer immune evasion pathways and specific cell targeting approaches based on tech licensed from Stanford. Forty Seven’s lead program, magrolimab , is a monoclonal antibody against the CD47 receptor, a ‘don’t eat me’ signal that cancer cells commandeer to avoid being ingested by macrophages. Evaluated ant ibodies are in many clinical studies of patients with myelodysplastic syndrome, acute myeloid leukemia, non-Hodgkin lymphoma, and solid tumors. These assets complement the cell therapy franchise Gilead added with its 2017 buy of Kite Pharma .     Beyond magrolimab , Forty Seven is fixing to advance two more compounds into clinical testing. Developing FSI-174, an anti-cKIT antibody, in combination with magrolimab creates a novel, all-antibody conditioning regimen to address ...
Read more